<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">The virus is known to enter the host cells by binding the S protein to ACE2 receptors. By developing neutralizing antibodies against the receptors, there is a high possibility for reducing the severity of the disease (
 <xref rid="bb0920" ref-type="bibr">Zheng and Song, 2020</xref>). Currently, only a handful of drugs have been approved for use against SARS-CoV-2.
</p>
